| Name | Title | Contact Details |
|---|
Aerohive delivers cloud networking that transforms the Connected Experience. Our simple, secure, and scalable mobility solutions build on cloud networking, great Wi-Fi, and applications and insights, to create the Connected Experience Platform, enabling organizations to leverage the power of mobility to increase productivity, engage customers, and grow their business. At Aerohive, we believe that every access point is a starting point.
Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk PCI and cardiogenic shock.
XRI Inc is a Warwick, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ceterix Orthopaedics is singularly focused on meniscal preservation and is dedicated to providing patients every opportunity to maintain the natural health and stability of their knee. The company develops tools that help surgeons repair many of the tears that currently remain untreated or are treated by meniscectomy (meniscus removal), a procedure associated with increased risk of arthritis or total knee replacement later in life. The Ceterix NovoStitch® Plus Meniscal Repair System provides surgeons with the unique ability to repair horizontal, radial, root and other complex tears. Based in Fremont, Calif., the company is backed by investors Novo Ventures, Versant Ventures and 5AM Ventures.
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.